Oncohematología y Genética

Biología de los procesos hematológicos (BioHem)

Ildefonso Espigado Tocino
Ildefonso Espigado Tocino

Ildefonso Espigado Tocino

Volver al programa
  1. Miembros del grupo
  2. Áreas de trabajo
  3. Publicaciones

Grupo: Biología de los procesos hematológicos (BioHem)

Directorio
Foto no disponible
  • Espigado Tocino, Ildefonso.Doctor en Medicina y Cirugía
  • Rodríguez Torres, Nancy.Lda. en Medicina y Cirugía

Áreas de trabajo

Revistas Internacionales
Solano, C; Vazquez, L; Gimenez, E; de la Camara, R; Albert, E; Rovira, M; Espigado, I; Calvo, CM; Lopez-Jimenez, J; Suarez-Lledo, M; Chinea, A; Esquirol, A; Perez, A; Bermudez, A; Saldana, R; Heras, I; Gonzalez-Huerta, AJ; Torrado, T; Batlle, M; Jimenez, S; Vallejo, C; Barba, P; Cuesta, MA; Pinana, JL; Navarro, D
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
BONE MARROW TRANSPLANTATION
Pinana, JL; Martino, R; Garcia-Garcia, I; Parody, R; Morales, MD; Benzo, G; Gomez-Catalan, I; Coll, R; De la Fuente, I; Luna, A; Merchan, B; Chinea, A; de Miguel, D; Serrano, A; Perez, C; Diaz, C; Lopez, JL; Saez, AJ; Bailen, R; Zudaire, T; Martinez, D; Jurado, M; Calbacho, M; Vazquez, L; Garcia-Cadenas, I; Fox, L; Pimentel, AI; Bautista, G; Nieto, A; Fernandez, P; Vallejo, JC; Solano, C; Valero, M; Espigado, I; Saldana, R; Sisinni, L; Ribera, JM; Jimenez, MJ; Trabazo, M; Gonzalez-Vicent, M; Fernandez, N; Talarn, C; Montoya, MC; Cedillo, A; Sureda, A
Risk factors and outcome of COVID-19 in patients with hematological malignancies
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
Burillo-Sanz S, Morales-Camacho RM, Caballero-Velázquez T, Carrillo E, Sánchez J, Pérez-López O, Pérez de Soto I, González Campos J, Prats-Martín C, Bernal R, Vargas MT.
MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Eur J Haematol.
Falantes JF, Márquez-Malaver FJ, Calderón-Cabrera C, Pedrote B, Martino ML, González J, Espigado I, Pérez-Simón JA.
Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome.
Clin Lymphoma Myeloma Leuk.
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I, GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation.
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
Blood Adv.
Medrano M, Carrillo-Cruz E, Montero I, Pérez-Simón JA.
Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications.
Int J Mol Sci.
Pardal E, Díez Baeza E, Salas Q, García T, Sancho JM, Monzón E, Moraleda JM, Córdoba R, de la Cruz F, Queizán JA, Rodríguez MJ, Navarro B, Hernández JA, Díez R, Vahi M, Viguria MC, Canales M, Peñarrubia MJ, González-López TJ, Montes-Moreno S, González-Barca E, Caballero D, Martín A, GELTAMO Spanish Collaborative Group.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group
Am J Hematol.
Prats-Martín C, Jiménez-Guerrero P, Morales-Camacho RM, Caballero-Velázquez T, Vargas MT, Pérez O, Montero I, Falantes J, Burillo-Sanz S, Carrillo E, Borrero JJ, Bernal R, Pérez-Simón JA.
KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.
Ann Hematol.